631862-75-4 Usage
Uses
Used in Pharmaceutical Industry:
N-[2-(2-AMINO-4-CHLOROPHENOXY)ETHYL]-N,N-DIMETHYLAMINE is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and improve existing ones.
Used in Agrochemical Industry:
In the agrochemical sector, N-[2-(2-AMINO-4-CHLOROPHENOXY)ETHYL]-N,N-DIMETHYLAMINE serves as an intermediate in the production of agrochemicals, helping to create more effective and targeted products for agricultural use.
Used in Research and Development:
N-[2-(2-AMINO-4-CHLOROPHENOXY)ETHYL]-N,N-DIMETHYLAMINE is also utilized in research and development for the creation of new chemical products, where its unique structure and properties can be explored for innovative applications.
It is crucial to handle N-[2-(2-AMINO-4-CHLOROPHENOXY)ETHYL]-N,N-DIMETHYLAMINE with care due to its potential risks to human health and the environment if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 631862-75-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,1,8,6 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 631862-75:
(8*6)+(7*3)+(6*1)+(5*8)+(4*6)+(3*2)+(2*7)+(1*5)=164
164 % 10 = 4
So 631862-75-4 is a valid CAS Registry Number.
631862-75-4Relevant academic research and scientific papers
PYRAZOLO[3,4-D]PYRIMIDINONE COMPOUNDS AS INHIBITORS OF THE P53/MDM2 INTERACTION
-
Page/Page column 64, (2014/08/07)
The invention relates to compounds of formula (I): as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
Pyrazolopyrrolidine compounds
-
Page/Page column 92, (2013/06/27)
The invention relates to compounds of formula (I) as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
Chk-1 inhibitors
-
, (2008/06/13)
Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
DIARYLUREA COMPOUNDS AND DERIVATIVES AS CHK-1 INHIBITORS FOR THE TREATMENT OF CANCER
-
Page 30, (2010/11/30)
Disclosed are novel inhibitors of Chk-1 and methods of using the same for therapy.
